You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 24, 2024

Selenious acid - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for selenious acid and what is the scope of patent protection?

Selenious acid is the generic ingredient in one branded drug marketed by Am Regent and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Selenious acid has six patent family members in six countries.

One supplier is listed for this compound.

Summary for selenious acid
International Patents:6
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 55
Clinical Trials: 3
Patent Applications: 2,070
What excipients (inactive ingredients) are in selenious acid?selenious acid excipients list
DailyMed Link:selenious acid at DailyMed
Recent Clinical Trials for selenious acid

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
American Regent, Inc.Phase 4
Shanghai Zhongshan HospitalN/A
Shanghai Changzheng HospitalN/A

See all selenious acid clinical trials

Paragraph IV (Patent) Challenges for SELENIOUS ACID
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
SELENIOUS ACID Intravenous Solution selenious acid 600 mcg/10 mL 209379 11 2024-06-11

US Patents and Regulatory Information for selenious acid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-003 Aug 30, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-001 Apr 30, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-002 Jan 25, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-002 Jan 25, 2021 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Am Regent SELENIOUS ACID selenious acid SOLUTION;INTRAVENOUS 209379-001 Apr 30, 2019 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for selenious acid

Country Patent Number Title Estimated Expiration
Australia 2021300384 Trace element compositions, methods of making and use ⤷  Sign Up
South Korea 20230058047 미량 원소 조성물, 그 제조 및 사용 방법 ⤷  Sign Up
China 116096423 微量元素组合物、制备方法及应用 (Microelement composition, preparation method and application) ⤷  Sign Up
European Patent Office 4175615 COMPOSITIONS D'OLIGO-ÉLÉMENTS, LEURS PROCÉDÉS DE FABRICATION ET D'UTILISATION (TRACE ELEMENT COMPOSITIONS, METHODS OF MAKING AND USE) ⤷  Sign Up
World Intellectual Property Organization (WIPO) 2022006426 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.